Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06875544

Clinical Performance of High Viscosity Bioactive Injectable Composite in Deep Marginal Elevation

Clinical Performance of High Viscosity Bioactive Injectable Composite in Deep Marginal Elevation Randomized Controlled Trail

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Future University in Egypt · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Using a bioactive resin composite in subgingival Class II cavities can provide enhanced caries resistance by releasing multiple ions, including fluoride. This approach offers greater resistance to caries due to the incorporation of surface pre-reacted glass filler (S-PRG) technology (Imazato, Nakatsuka et al., 2023). This type of composite may improve the outcomes of deep subgingival margin elevation, benefiting both restorative success and periodontal health.

Conditions

Interventions

TypeNameDescription
OTHERBeautifil F00Beautifil F00 is bioactive giomer resin composite.
OTHERG-aenial Universal Injectable Flowable CompositeNanohybrid resin composite is a type of restorative material that features nano-sized fillers as a main component

Timeline

Start date
2025-03-01
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2025-03-13
Last updated
2025-03-13

Source: ClinicalTrials.gov record NCT06875544. Inclusion in this directory is not an endorsement.